Literature DB >> 28990152

Therapeutic Targets for the Multi-system Pathophysiology of Heart Failure: Exercise Training.

Erik H Van Iterson1, Thomas P Olson2.   

Abstract

OPINION STATEMENT: Adult chronic heart failure (HF) is a terminal syndrome. While the HF phenotype is inhomogeneous across the ejection fraction spectrum, exercise intolerance remains a cardinal feature of all HF patients. Impairment of a single organ system cannot independently account for exercise intolerance in HF. Thus, the multi-system integrative pathophysiology of HF leads to challenges in identifying an effective medical therapy aimed at targeting a single mechanism to improve exercise tolerance. This unresolved medical care approach raises a number of points for discussion in this field as it is well-recognized that exercise intolerance is accompanied by increased hospitalizations and mortality across the HF spectrum. Practitioner-guided individualized exercise training represents an intrinsic multi-level therapeutic approach that inclusively "targets" integrated physiological systems. A rapidly evolving body of evidence provides firm support that structured exercise therapy is safe while leading to improved exercise tolerance (peak oxygen uptake [V̇O2]) followed by reduced hospitalizations and cardiovascular mortality across the HF spectrum. The benefits of guided exercise therapy in HF have been directly attributed to integrative improvements in peak V̇O2, skeletal muscle strength, cardiac function, micro- to macro-vascular function, circulation/organ perfusion, and nervous system function, among others. Despite the sound clinical evidence in support of exercise-based medical care, there remains an appreciable gap in translation of current scientific evidence and implementation of this therapeutic paradigm into routine clinical practice as well as universal insurance coverage for HF patients. In the following review, the theme of discussion is framed in a manner that carries a sense of urgency for the need to increase awareness of the up-to-date evidence-based support for the clinical implementation of structured exercise therapy as a necessary routine component of primary medical care practices for reducing hospitalizations, morbidity, and mortality in all HF patients.

Entities:  

Keywords:  Cardiac rehabilitation; Chronic heart failure; Exercise intolerance; Exercise training therapy; HFpEF; HFrEF

Year:  2017        PMID: 28990152     DOI: 10.1007/s11936-017-0585-8

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  71 in total

1.  Effects of respiratory muscle work on blood flow distribution during exercise in heart failure.

Authors:  Thomas P Olson; Michael J Joyner; Niki M Dietz; John H Eisenach; Timothy B Curry; Bruce D Johnson
Journal:  J Physiol       Date:  2010-05-10       Impact factor: 5.182

2.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  J Am Coll Cardiol       Date:  2017-04-28       Impact factor: 24.094

3.  Effect of resistance training on physical disability in chronic heart failure.

Authors:  Patrick A Savage; Anthony O Shaw; Mark S Miller; Peter VanBuren; Martin M LeWinter; Philip A Ades; Michael J Toth
Journal:  Med Sci Sports Exerc       Date:  2011-08       Impact factor: 5.411

Review 4.  Publication trends in cachexia and sarcopenia in elderly heart failure patients.

Authors:  Jochen Springer; Stefan D Anker
Journal:  Wien Klin Wochenschr       Date:  2016-11-24       Impact factor: 1.704

5.  The addition of strength training to aerobic interval training: effects on muscle strength and body composition in CHF patients.

Authors:  Anthi Bouchla; Eleftherios Karatzanos; Stavros Dimopoulos; Athanasios Tasoulis; Varvara Agapitou; Nikolaos Diakos; Eleni Tseliou; John Terrovitis; Serafim Nanas
Journal:  J Cardiopulm Rehabil Prev       Date:  2011 Jan-Feb       Impact factor: 2.081

6.  Impact of a home-based walking and resistance training program on quality of life in patients with heart failure.

Authors:  R K Oka; T De Marco; W L Haskell; E Botvinick; M W Dae; K Bolen; K Chatterjee
Journal:  Am J Cardiol       Date:  2000-02-01       Impact factor: 2.778

7.  Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.

Authors:  J L Rouleau; M A Pfeffer; D J Stewart; D Isaac; F Sestier; E K Kerut; C B Porter; G Proulx; C Qian; A J Block
Journal:  Lancet       Date:  2000-08-19       Impact factor: 79.321

Review 8.  Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation.

Authors:  Massimo Francesco Piepoli; Ugo Corrà; Werner Benzer; Birna Bjarnason-Wehrens; Paul Dendale; Dan Gaita; Hannah McGee; Miguel Mendes; Josef Niebauer; Ann-Dorthe Olsen Zwisler; Jean-Paul Schmid
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-02

9.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

10.  Physiological dead space and arterial carbon dioxide contributions to exercise ventilatory inefficiency in patients with reduced or preserved ejection fraction heart failure.

Authors:  Erik H Van Iterson; Bruce D Johnson; Barry A Borlaug; Thomas P Olson
Journal:  Eur J Heart Fail       Date:  2017-10-08       Impact factor: 15.534

View more
  3 in total

1.  Alveolar Air and O2 Uptake During Exercise in Patients With Heart Failure.

Authors:  Erik H Van Iterson; Joshua R Smith; Thomas P Olson
Journal:  J Card Fail       Date:  2018-08-10       Impact factor: 5.712

2.  Invasive Hemodynamic and Metabolic Evaluation of HFpEF.

Authors:  J Emanuel Finet; Erik H Van Iterson; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-03-26

Review 3.  Left Ventricular Assist Device Support Complicates the Exercise Physiology of Oxygen Transport and Uptake in Heart Failure.

Authors:  Erik H Van Iterson
Journal:  Card Fail Rev       Date:  2019-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.